cimb-logo

Journal Browser

Journal Browser

Therapeutic Effects of Natural Bioactive Compounds in the Management of Human Diseases: 2nd Edition

A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Biochemistry, Molecular and Cellular Biology".

Deadline for manuscript submissions: 31 March 2026 | Viewed by 701

Special Issue Editors


E-Mail Website
Guest Editor
Department of Chemical Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy
Interests: human physiology; cell physiology; membrane transport systems; bioactive compound; oxidative stress; human health
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The Special Issue, entitled “Therapeutic Effects of Natural Bioactive Compounds in the Management of Human Diseases: 2nd Edition”, welcomes high-quality research articles and review articles focusing on targets and molecular mechanisms underlying several common pathological conditions related to increased oxidative stress and inflammatory processes and their possible modulation through natural bioactive compounds. Recently, these molecules have attracted considerable attention due to their potential employment as low-toxicity therapies that can prevent or reduce chronic disease-induced damage or restore damaged cells.

The extraordinary activity of functional bioactives is displayed via their antioxidant, anti-inflammatory, and anti-glycant properties, which collectively provide a potential new strategy in the management of several pathological conditions (e.g., diabetes, obesity, and rheumatic and neurodegenerative diseases, among others). Understanding the molecular and functional mechanisms and/or pathways through which these substances may support human health remains an open question worth exploring. From this perspective, studies using animal, as well as cell-based models, are welcome.

Prof. Dr. Rossana Morabito
Dr. Sara Spinelli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural bioactive compound
  • human health
  • chronic diseases
  • molecular target
  • oxidative stress
  • inflammation
  • cancer
  • diabetes

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 8897 KB  
Article
Chemical Composition of Clove and Fennel Seed Essential Oils and a Comparison of Their In Silico and In Vitro Antibacterial Activity with That of Their Main Compounds
by Achraf Abdou, Fatima Ezzahra Maaghloud, Fatima Zahra Kamal, Said Rammali, Alin Ciobica, Vasile Burlui, Cristina Albert, Abdelhakim Elmakssoudi, Bogdan Novac and Mohamed Dakir
Curr. Issues Mol. Biol. 2025, 47(9), 694; https://doi.org/10.3390/cimb47090694 - 27 Aug 2025
Viewed by 611
Abstract
This study aimed to assess the chemical composition and antibacterial potential of essential oils (EOs) from two plants: clove buds (Syzygium aromaticum) and fennel seeds (Foeniculum vulgare) EOs. The major compounds, eugenol and estragole, were isolated from these oils [...] Read more.
This study aimed to assess the chemical composition and antibacterial potential of essential oils (EOs) from two plants: clove buds (Syzygium aromaticum) and fennel seeds (Foeniculum vulgare) EOs. The major compounds, eugenol and estragole, were isolated from these oils and tested against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The EOs were obtained via hydrodistillation and analyzed using Gas Chromatography–Mass Spectrometry (GC-MS). Clove oil was found to be rich in eugenol (68.51%), while fennel seed oil was dominated by estragole (93.30%). Antibacterial activity, assessed by the agar disc diffusion method and supported by MIC/MBC testing, revealed that eugenol exhibited the highest efficacy, with MIC values ranging from 0.58 to 1.15 mg/mL and MBC values from 1.15 to 2.30 mg/mL, particularly against S. aureus and P. aeruginosa. In silico analysis was conducted to evaluate pharmacokinetics, toxicity, and molecular docking interactions. ADME predictions indicated good oral bioavailability and high membrane permeability for both compounds, with eugenol displaying superior solubility and better compliance with Lipinski’s Rule of Five. Molecular docking simulations confirmed the antibacterial potential, with eugenol showing stronger binding affinities to bacterial targets (−7.8 kcal/mol), forming more stable and diverse interactions compared to estragole. However, toxicity predictions indicated potential mutagenic, carcinogenic, and cardiotoxic (hERG inhibition) risks for both compounds. Full article
Show Figures

Graphical abstract

Back to TopTop